Category Archives: food death

USA – FDA: Salmonella removed from Infant Formula Outbreak – Cronobacter sakazakii still cause of 4 illnesses with 2 deaths

Food Poison Journal

Total Adverse Events: 4
Hospitalizations: 4
Reported Deaths: 2
Illness Onset Date Range: 9/6/2021 – 1/4/2022
States with Adverse Events: MN (1), OH (2), TX (1)
Product Distribution: Nationwide and International

The FDA, along with CDC and state and local partners are investigating consumer complaints and/or reports of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility. All of the ill patients are reported to have consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, MI facility.

The Salmonella Newport illness previously included in this investigation of complaints and illnesses has been removed. In the early stages of this investigation, FDA included all consumer complaints of illness with exposure to products from the Sturgis, MI, facility. After further investigation, the FDA has determined that there is not enough information to definitively link this illness to powdered infant formula. CDC confirmed that this single Salmonella illness is not linked to an outbreak. The FDA and CDC are continuing to monitor for Salmonella cases and consumer complaints that may be related to this incident.

Cronobacter infection surveillance is not handled the same way as infection with more common foodborne pathogens, such as Salmonella or E. coli O157:H7. Cronobacter is not nationally notifiable and not reportable except in one state, which means doctors and labs are not required to report cases to their health department. Because Cronobacter is not a nationally notifiable pathogen, FDA relies on consumer complaints of illness sent to the Agency and on health care providers informing FDA directly about infants with Cronobacter infections. In addition, because Cronobacter is not nationally notifiable, whole genome sequencing (WGS) is rarely performed on these isolates. To date, no outbreaks of Cronobacter have been detected using WGS.

When single cases of Cronobacter are reported, the FDA conducts a thorough review of each complaint, conducts sampling of products, and initiates inspections as appropriate. FDA collaborates with CDC, which has developed a detailed questionnaire specifically for Cronobacter infections that is often used by state health departments in instances of Cronobacter sakazakii infection.

USA – Outbreak Investigation of Listeria monocytogenes: Fresh Express Packaged Salad (December 2021) is Over.

FDA

The FDA and CDC, in collaboration with state and local partners, investigated a multistate outbreak of Listeria monocytogenes infections. According to the CDC, as of March 8, 2022, this outbreak has ended.

On December 20, 2021, Fresh Express voluntarily recalled certain varieties of its branded and private label salad products produced at the company’s Streamwood, Illinois, facility.

Recommendation

On March 8, 2022, CDC announced this outbreak is over. The product is past expiration and should no longer be available to consumers. Therefore, there are no recommendations for consumers, retailers, or suppliers.

FDA recommends that anyone who received recalled products use extra vigilance in cleaning and sanitizing any surfaces and containers that may have come in contact with these products to reduce the risk of cross-contamination. Listeria can survive in refrigerated temperatures and can easily spread to other foods and surfaces.


Product Images

Image – Bagged Salad, Use By Date

Map of U.S. Distribution of Recalled Packaged Salad

Outbreak Investigation of Listeria monocytogenes: Packaged Salad: Case Count Map Provided by CDC (December 21, 2021)

Case Count

People infected with the outbreak strain of Listeria monocytogenes by state of residence, as of March 8, 2022 (n=10)

Case Counts People infected with the outbreak strain of Listeria monocytogenes by state of residence, as of March 8, 2022 (n=10)

Case Counts

Total Illnesses: 10
Hospitalizations: 10
Deaths: 1
Last Illness Onset: October 19, 2021
States with Cases: IL, MA, MI, NJ, NY, OH, PA, VA

USA – Abbott Voluntarily Expands Recall of Powder Formulas Manufactured at One Plant – Cronobacter – Salmonella

FDA

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Food & Beverages
Foodborne Illness
Reason for Announcement:
Consumer complaints regarding Cronobacter sakazakii, Salmonella Newport
Company Name:
Abbott
Brand Name:
Similac, Alimentum, and EleCare
Product Description:
Powder Infant Formula

Company Announcement

02.28.2022 EXPANDED: Abbott is voluntarily recalling one lot of Similac PM 60/40 (Lot # 27032K80 (can) / Lot # 27032K800 (case)) manufactured in Sturgis, Michigan. This is in addition to lots of Similac®, Alimentum® and EleCare® powder formula that were voluntarily recalled on Feb. 17. The action comes after learning of the death of an infant who tested positive for Cronobacter sakazakii and who we were informed had consumed Similac PM 60/40 from this lot. This case is under investigation, and at this time the cause of the infant’s Cronobacter sakazakii infection has not been determined. We want to extend our heartfelt sympathies to the family.

Importantly, no distributed product has tested positive for the presence of Cronobacter sakazakii. Additionally, recently tested retained product samples of Similac PM 60/40 Lot # 27032K80 (can) / Lot #27032K800 (case) were negative for Cronobacter.

02.17.2022 Abbott initiated a proactive, voluntary recall of powder formulas, including Similac, Alimentum and EleCare, manufactured in Sturgis, Michigan, one of the company’s manufacturing facilities. The recall does not include any metabolic deficiency nutrition formulas.

Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility.

Additionally, as part of Abbott’s quality processes, we conduct routine testing for Cronobacter sakazakii and other pathogens in our manufacturing facilities. During testing in our Sturgis, Michigan, facility, we found evidence of Cronobacter sakazakii in the plant in non-product contact areas. We found no evidence of Salmonella Newport. This investigation is ongoing.

Importantly, no distributed product has tested positive for the presence of either of these bacteria, and we continue to test. Abbott conducts extensive quality checks on each completed batch of infant formula, including microbiological analysis prior to release. All finished  infant formula powder products are tested for Cronobacter, Salmonella, and other pathogens, and they must test negative before the product is released. Additionally, retained samples related to the three complaints for Cronobacter sakazakii tested negative for Cronobacter. And the retained sample related to the complaint for Salmonella Newport tested negative for Salmonella.

While Abbott’s testing of distributed product detected no pathogens, we are taking action by recalling the powder formula manufactured in this facility with an expiration of April 1, 2022, or later. No Abbott liquid formulas are included in the recall, nor are powder formulas or nutrition products from other facilities.

If your infant is experiencing symptoms related to Cronobacter or Salmonella infection, such as poor feeding, irritability, temperature changes, jaundice, grunting breaths, abnormal movements, lethargy, rash, or blood in the urine or stool; contact your health care provider to report their symptoms and receive immediate care.

To find out if the product you have is included in this recall, click on the button below to check your lot number.

Link to Initial Press Release


Company Contact Information

Consumers:
Abbott
 +1-800-986-8540
Media:
Vicky Assardo
 (224) 668-1505

USA – FDA Core Investigation Table Update

FDA

Date
Posted
Ref
Pathogen
Product(s)
Linked to
Illnesses

(if any)
Total
Case Count

Status
2/17/2022 1056 Cronobacter
sakazakii

&
Salmonella
Newport
Powdered
Infant
Formula
See
Advisory
Active
2/9/2022 1040 Listeria
monocytogenes
Not Yet
Identified
14 Active
2/2/2022 1054 Enteroinvasive
E. coli
O143:H26
Not Yet
Identified
16 Closed
1/10/2022 1050 E. coli
O121:H19
Romaine 4 Closed
12/29/2021 1052 E. coli
O157:H7
Packaged
Salad
See Outbreak
Advisory
Closed
12/20/2021 1039 Listeria
monocytogenes
Packaged
Salad
See Outbreak
Advisory
Active
12/15/2021 1048 Listeria
monocytogenes
Packaged
Salad
See Outbreak
Advisory
Active

USA – Senators Ask Abbott Nutrition to Explain Cronobacter Infant Illnesses

Food Poisoning Bulletin

Senators ask Abbott Nutrition to explain the Cronobacter and Salmonella illnesses associated with certain types of their Similac, EleCare, and Alimentum powdered infant formulas. A letter was sent to the chairman of the board by two Senators: Patty Murray (D-WA) and Robert Casey Jr. (D-PA). Senator Casey is the Chairman of the Subcommittee on Children and Families in the Senate, and both Senators are members of the U.S. Senate Commitee on Health, Education, Labor and Pensions.

USA – FDA Investigation of Cronobacter and Salmonella Complaints: Powdered Infant Formula (February 2022)

FDA

If you want to check if your powdered formula is part of the recall, you can enter the product lot code on the bottom of your package on the company’s websiteExternal Link Disclaimer.

If you have questions or need information about the recall, you can Submit Questions/Get Assistance.

If your infant is experiencing symptoms related to Cronobacter or Salmonella infection, such as poor feeding, irritability, temperature changes, jaundice, grunting breaths, abnormal movements, lethargy, rash, or blood in the urine or stool; contact your health care provider to report their symptoms and receive immediate care.

To report an illness or adverse event, you can

The FDA, along with CDC and state and local partners are investigating consumer complaints and/or reports of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility. All of the ill patients are reported to have consumed powdered infant formula produced from Abbott Nutrition’s Sturgis, MI facility.

As of February 28, CDC has announced one additional illness of Cronobacter sakazakii with exposure to powdered infant formula produced at Abbott Nutrition’s Sturgis, MI facility. Cronobacter infection may have been a contributing cause of death for this patient. In total, this investigation includes four reports of Cronobacter sakazakii infections in infants (three from FDA complaints and one from a CDC case finding) and one complaint of a Salmonella Newport infection in an infant. All five (four Cronobacter infections and one Salmonella Newport infection) illnesses resulted in hospitalization and Cronobacter may have contributed to death in two patients.

The most recent patient was reported to have consumed Abbott Nutrition’s Similac PM 60/40 product with the lot code 27032K800 prior to Cronobacter sakazakii infection. FDA and CDC informed the firm of these findings and on February 28, 2022, Abbott Nutrition voluntarily recalled Similac PM 60/40 powdered infant formula with the lot code 27032K800. This is a specialty formula for certain infants who would benefit from lowered mineral intake and was not included in the previous recall. At this time, Similac PM 60/40 with lot code 27032K80 (can) / 27032K800 (case) are the only type and lots of this specialty formula being recalled.

This particular lot of Similac PM 60/40 was distributed to the U.S. and Israel. If your regular formula is not available, contact your child’s healthcare provider for recommendations on changing feeding practices.

We understand that infant formula is the sole source of nutrition for many infants and is an essential product. FDA is working with Abbott Nutrition to better assess the impacts of the recall and understand production capacity at other Abbott facilities that produce some of the impacted brands. We are also working with Abbott Nutrition on safe resumption of production at the Sturgis, MI facility. FDA is continuing to investigate and will update this advisory should additional consumer safety information become available.

Recommendation

The FDA is advising consumers not to use recalled Similac, Alimentum, or EleCare powdered infant formulas. Recalled products can be identified by the 7 to 9 digit code and expiration date on the bottom of the package (see image below). Products are included in the recall if they have all three items below:

  • the first two digits of the code are 22 through 37 and
  • the code on the container contains K8, SH, or Z2, and
  • the expiration date is 4-1-2022 (APR 2022) or later.

In addition to products described above, Abbott Nutrition has recalled Similac PM 60/40 with a lot code 27032K80 (can) / 27032K800 (case). At this time, Similac PM 60/40 with lot code 27032K80 (can) / 27032K800 (case) are the only type and lots of this specialty formula being recalled.

Additional recall information for the initial recall is available on the FDA website. Parents can also enter their product lot code on the company’s websiteExternal Link Disclaimer to check if it is part of the recall.

Additional Information for Parents and Caregivers:

The recalls do not include liquid formula products. Consumers should continue to use all product not included in the recalls.

Parents and caregivers should never dilute infant formula and should not make or feed homemade infant formula to infants. Consumers should also avoid purchasing imported formula through online sales, as it has the potential to be counterfeit.

If your regular formula is not available, contact your child’s healthcare provider for recommendations on changing feeding practices.

If you get infant formula through WIC, do not throw the formula out. Instead, you should take it to the store for a refund and exchange or call the company at 1-800-986-8540 to help you. WIC recipients should be able to obtain a different brand of similar formula. Call your local WIC clinic for more guidance. Also see:

More information on Cronobacter and infant formula is available on CDC’s website.

Recalled powdered infant formulas have the potential to be contaminated with Cronobacter, a bacterium that can cause severe foodborne illness primarily in infants. Cronobacter infections are rare but are especially high risk for newborn infants (see symptoms below).

Cronobacter bacteria can cause severe, life-threatening infections (sepsis) or meningitis (an inflammation of the membranes that protect the brain and spine). Symptoms of sepsis and meningitis may include poor feeding, irritability, temperature changes, jaundice (yellow skin and whites of the eyes), grunting breaths, and abnormal movements. Cronobacter infection may also cause bowel damage and may spread through the blood to other parts of the body.

If your child is experiencing any of these symptoms, you should notify your child’s healthcare provider and seek medical care for your child immediately. Healthcare providers and health departments are encouraged to report any confirmed cases of Cronobacter sakazakii to CDC.


Product Images

Sample Product Image from the FDA Investigation of Cronobacter and Salmonella Complaints about Powdered Infant Formula (February 2022)
Sample Product Image from the FDA Investigation of Cronobacter and Salmonella Complaints about Powdered Infant Formula (February 2022)
Powdered Infant Formation Container with Product Coding

Case Counts

Total Adverse Events: 5 (4 Cronobacter, 1 Salmonella)
Hospitalizations: 5
Reported Deaths: 2*
Adverse Event Dates: 9/16/2021 – 1/4/2022
States with Adverse Events: MN (1), OH (2), TX (2)
Product Distribution: Nationwide and International
* Two deaths have been reported. Cronobacter infection may have contributed to the cause of death for both ill patients.


International Product Distribution

The recall impacts Alimentum, EleCare, and Human Milk Fortifier for markets outside the U.S. No other Abbott Nutrition products distributed outside of the U.S. are affected by this recall. According to the firm, recalled products were distributed to the following countries/locations: Australia, Bahrain, Barbados, Bermuda, Canada, Chile, China, Colombia, Costa Rica, Dominican Republic, Ecuador, Egypt, Guam, Guatemala, Hong Kong, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Malaysia, Mexico, New Zealand, Oman, Peru, Puerto Rico, Qatar, Saudi Arabia, Singapore, South Africa, Sudan, Taiwan, Thailand, United Arab Emirates, United Kingdom, and Vietnam ANI South.

For additional information, international officials and customers can visit the company’s recall page for contact informationExternal Link Disclaimer.

Cronobacter Surveillance

Cronobacter infection surveillance is not handled the same way as infection with more common foodborne pathogens, such as Salmonella or E. coli O157:H7. Cronobacter is not nationally notifiable and not reportable except in one state, which means doctors and labs are not required to report cases to their health department. Because Cronobacter is not a nationally notifiable pathogen, FDA relies on consumer complaints of illness sent to the Agency and on health care providers informing FDA directly about infants with Cronobacter infections. In addition, because Cronobacter is not nationally notifiable, whole genome sequencing (WGS) is rarely performed on these isolates. To date, no outbreaks of Cronobacter have been detected using WGS.

When single cases of Cronobacter are reported, the FDA conducts a thorough review of each complaint, conducts sampling of products, and initiates inspections as appropriate. FDA collaborates with CDC, which has developed a detailed questionnaire specifically for Cronobacter infections that is often used by state health departments in instances of Cronobacter sakazakii infection.

USA – Baby formula recall expands to include Similac PM after another baby dies of Cronobacter

USA Today

Abbott Nutrition’s baby formula recall has been expanded to include one lot of Similac PM 60/40.

The Food and Drug Administration said in an update Monday that health officials were investigating an additional illness of Cronobacter sakazakii with exposure to powdered infant formula produced at the company’s Sturgis, Michigan facility. That baby also died of Cronobacter.

“The most recent patient was reported to have consumed Abbott Nutrition’s Similac PM 60/40 product with the lot code 27032K800 prior to Cronobacter sakazakii infection,” the FDA said.

Similac PM is considered “a specialty formula for certain infants who would benefit from lowered mineral intake.” It was not included in the previous recall for select lots of Similac, Alimentum and EleCare formulas announced Feb. 17.

RECALL DATABASE:  Check USA TODAY’s recall resource for the latest updates

USA – FDA – Infant Formula Recall: What to Know

FDA

If you use powdered infant formula, be aware certain Similac, Alimentum and EleCare products have been recalled and should not be used.

The U.S. Food and Drug Administration (FDA) is investigating consumer complaints of bacterial infections in five infants who consumed powdered infant formula produced in Abbott Nutrition’s facility in Sturgis, Michigan. All five infants had to be hospitalized and the bacterial infection may have contributed to death in two patients.

Because infant formula is the only source of nutrition for many newborns and infants, the FDA understands and shares the concerns parents and caregivers may have.

Here’s information to help you as we continue our investigation.

What powdered infant formula products have been recalled?

Abbott Nutrition has recalled certain powdered infant formula products produced at its Sturgis, Michigan facility. Products from that facility can be found across the U.S. and some were exported to other countries. Here’s how you can tell if you have any of those products.

The FDA recommends consumers look at the lot code, a multidigit number on the bottom of a container of Similac, Alimentum and EleCare powdered infant formula and do not use if:

  • the first two digits of the code are 22 through 37; and
  • the code on the container contains K8, SH or Z2; and
  • the expiration date is 4-1-2022 (APR 2022) or later.

In addition to products described above, Abbott Nutrition has recalled Similac PM 60/40 with a lot code of 27032K80 (can) / 27032K800 (case).

You can also enter your product lot code on the company’s websiteExternal Link Disclaimer to check if it is part of the recall. Please see the images below for a closer look at the identifying information.

Powdered Abbott products that don’t have the code and expiration noted above are not included in the recall. Liquid formula products are not subject to the recall. At this time, Similac PM 60/40 with lot code 27032K80 (can) / 27032K800 (case) are the only type and lots of this specialty formula being recalled.

Top of Infant Formula can displaying number coding.
Top of Powdered Infant Formula can, displaying dates and number coding.
Bottom of Powdered Infant formula container

What infections have been reported and what symptoms should I look for?

Four cases involve Cronobacter sakazakii, and one involves Salmonella Newport infection.

  • Cronobacter bacteria can cause severe, life-threatening infections (sepsis) or meningitis (an inflammation of the membranes that protect the brain and spine). Cronobacter infections are rare but are especially high risk for newborns.
  • Salmonella are a group of bacteria that can cause gastrointestinal illness and fever called salmonellosis.
  • Symptoms related to Cronobacter and Salmonella infection include: poor feeding, irritability, temperature changes, jaundice, grunting breaths, abnormal body movements, lethargy, rash or blood in the urine or stool.
  • If your infant is experiencing symptoms related to Cronobacter or Salmonella infection, contact your child’s health care provider to report his or her symptoms and receive immediate care.

When and where were the illnesses?

Illnesses occurred in Minnesota, Ohio, and Texas between September 16, 2021 and January 4, 2022.

I’m having a hard time finding formula. What is the FDA doing to help?

We are aware the recall has created new concerns about the availability of certain types of infant formula, particularly given the overall strains on supply chains experienced during the COVID-19 pandemic.

The FDA is working with Abbott Nutrition to better assess the impacts of the recall and understand the production capacity at other Abbott facilities that produce some of the impacted brands. We are also working with Abbott on safe resumption of production at the Sturgis, Michigan facility. As Abbott Nutrition was initiating its recall, the FDA intensified outreach to other infant formula manufacturers to inquire about their capacity and potential impacts. We will continue discussion with Abbott Nutrition and other infant formula manufacturers and consider all tools available to support the supply of infant formula products.

Are homemade formulas an alternative?

No. The FDA advises parents and caregivers not to make or feed homemade formula to infants. Homemade infant formula recipes have not been evaluated by the FDA and may lack nutrients vital to an infant’s growth.

What else should I know?

Parents and caregivers also should never dilute infant formula. Consumers also should avoid buying formula online that comes from outside the U.S., as it has the potential to be counterfeit.

If your regular formula is not available, contact your child’s health care provider for recommendations on changing feeding practices.

If you get infant formula through WIC, do not throw the formula out. Instead, you should take it to the store for a refund and exchange or call the company at 1-800-986-8540 to help you. WIC recipients should be able to obtain a different brand of similar formula. Call your local WIC clinic for more guidance.

Additional Resources:

USA – Cronobacter Illnesses Linked to Powdered Infant Formula

CDC

On February 17, Abbott three brands of formula produced at its manufacturing facility in Sturgis, Michigan. Parents and caregivers of newborns should not feed their baby recalled Similac, Alimentum, or EleCare powdered infant formulas.

Fast Facts
  • Illnesses: 3
  • Deaths: 1
  • States: 3 (Minnesota, Ohio, Texas)
  • Recall: Yes
  • Investigation status: Active
Powdered infant formula container with product coding

Recalled Powdered Infant Formula

On February 17, Abbott recalledexternal icon three brands of formula produced at its manufacturing facility in Sturgis, Michigan.

Recalled Similac, Alimentum, or EleCare powdered formula have all three of these conditions:

  • First two digits of the code are 22 through 37, AND
  • Code on the container contains “K8,” “SH,” or “Z2,” AND
  • Use-by date is 4-1-2022 (APR 2022) or later.

To find out if the product you have is included in this recall, review these codes in the bottom of the package. See the recall noticeexternal icon for more information.

What Parents and Caregivers Should Do

Do not feed your baby any recalled powdered formula.

Contact your baby’s healthcare provider if:

  • Your baby has symptoms of Cronobacter illness (fever and poor feeding, excessive crying, or very low energy).
  • Your regular formula is not available, and you need recommendations on other ways to feed your baby.
Symptoms
  • The first symptom of Cronobacter infection in infants (0–1 year old) is usually a fever, accompanied by poor feeding, excessive crying, or very low energy. Some infants may also have seizures. Infants with these symptoms should be seen by a medical provider as soon as possible.
  • Cronobacter germs can cause a dangerous blood infection (sepsis) or make the linings surrounding the brain and spinal cord swell (meningitis). Infections in infants usually occur in the first days or weeks of life. Infants 2 months of age and younger are most likely to develop meningitis if they are infected with Cronobacter.
What Healthcare Providers/Laboratories Should Do
  • If a Cronobacter infection is diagnosed by a laboratory culture, CDC encourages clinicians and laboratories to inform their local or state health department.
  • Cronobacter can be detected in the blood or cerebrospinal fluid (CSF) of patients with meningitis or sepsis caused by these bacteria. Cronobacter bacteria grow on routine culture media and microbiological laboratories can detect Cronobacter from blood or CSF samples.
  • CDC does not recommend testing infants for Cronobacter infection unless they have symptoms of meningitis or sepsis, even if they consumed recalled formula.
  • CDC does not recommend testing stool for CronobacterCronobacter infection does not typically cause diarrhea in infants.
  • CDC does not recommend testing formula for Cronobacter contamination unless an infant has a diagnosed Cronobacter infection.
alert icon
Please contact your local or state health department if your child has been diagnosed with Cronobacter infection and consumed recalled formula.
Description of Cases

On February 10, 2022, CDC was notified of FDA’s investigation of consumer complaints of infant illness related to products from Abbott Nutrition in Sturgis, Michigan. These complaints include three reports of Cronobacter sakazakii infections and one report of Salmonella Newport infection in infants. CDC and FDA are conducting additional laboratory testing and investigation to better understand these cases.

The most recent investigation details are summarized below:

From September 16, 2021, to January 5, 2022, CDC received reports of three Cronobacter cases in infants that were later found to be linked to this ongoing investigation:

  • Three infants in Minnesota, Ohio, and Texas consumed formula produced at the Sturgis, Michigan, facility before they got sick. Formula consumed included Similac Sensitive, Similac Pro-total Comfort, and Similac Advance. Cronobacter may have contributed to the death of an infant in Ohio.
  • These are the same cases identified in the consumer complaints received by FDA.

On February 16, 2022, CDC asked clinicians and state and local health departments to provide information on other cases of Cronobacter associated with infant formula from November 2020 through the present. Since then, CDC has received reports of more possible cases of Cronobacter illnesses in infants who might have consumed recalled formula. CDC is investigating to determine if these cases are linked to formula products produced at the Abbott Nutrition facility in Sturgis, Michigan. CDC is performing whole genome sequencing on Cronobacter bacteria isolated from available patient samples to compare with the environmental samples taken at the facility to determine if there is any relation.

CDC’s routine outbreak surveillance has not detected an outbreak of Salmonella illnesses linked to the case reported to FDA.

About Cronobacter

Cronobacter sakazakii is a germ found naturally in the environment and can live in very dry places. The germs can live in dry foods, such as powdered infant formula, powdered milk, herbal teas, and starches. Cronobacter infection is not reportable in most states, meaning doctors are not required to report cases to their health department. Cronobacter illnesses are rare, but when infections happen, they can be deadly for infants. CDC typically receives reports of 2 to 4 infections in infants per year, but the total number of cases that occur in the United States each year is not known.

How Cronobacter Can Spread
  • At a production factory, Cronobacter could get into formula powder if contaminated raw materials are used to make the formula or if the formula powder touches a contaminated surface in the manufacturing environment.
  • Powdered infant formula could also become contaminated at home or elsewhere after the container is opened. For example, Cronobacter could get into the formula if formula lids or scoops are placed on contaminated surfaces and later touch the formula or if the formula is mixed with contaminated water or in a contaminated bottle. See more information on how to safely prepare and store powdered infant formula.

Singapore – Recall of Abbott Alimentum powdered infant formula from USA due to possible presence of Cronobacter sakazakii and Salmonella Newport

Click to access sfa-media-release—20220223-recall-of-abbott-alimentum-and-similac-hmf.pdf

Updated media release:

Update on 19Feb 2022:Further to the media release on 19 Feb 2022, SFA has directed the recall of an additional affected product –Similac Human Milk Fortifier (HMF).The recall for both affected products have been completed. Parents or caregivers who are concerned should stop using these products. They should seek medical assistance should their infants feel unwell after consuming the affected products.

Consumers may reach out to the importer, Abbott Laboratories (S) Pte Ltd, at 6278 6220 or email to family.sg@abbott.com for any clarification.